Investigator Site

Zurich

0 studies enrolling now · 2 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura

Studies at this site

• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed